Dysregulation in the global G6Pase system has been implicated in various cancers, including ovarian cancer and HCC (21, 24), but the specific contributions of the G6PC1-3 and SLC37A1-4 isoforms remains unclear. This evidence concerns the gene G6PC1 and cancer.